- Solutions
Our solutions
- OverviewOur workflow solutions give you the data, tools, and insights to power every decision
- Strategic IntelligenceGet a complete view of strategic issues and stay ahead of emerging disruptive themes
- Sales IntelligenceOur workflow solutions give you the data, tools, and insights to power every decision
- Industry
- Platform
Our platform
Your powerful intelligence platform
Explore the fully comprehensive productivity and insights platform
- Company
We are GlobalData
The total mobile services revenue in the Philippines is set to increase at a compound annual growth rate (CAGR) of 2.7% from $3.8 billion in 2023 to $4.3 billion in 2028, mainly due to the rising adoption of mobile data services, according to GlobalData, a leading data and analytics company. According to Global Data’s Philippines […]
Critical minerals key to transition to low-carbon world, says GlobalData
Green energy technologies are in demand worldwide. Over 70 countries have set net-zero targets, and even more have pledged to lower their emissions. However, ambitious objectives to scale up green energy sources such as solar, wind, and nuclear are straining natural resources, particularly the minerals required to produce these essential technologies. With more than 50 […]
US card payments market to grow at 7.8% CAGR to $13.9 billion in 2027, forecasts GlobalData
The US card payments market is expected to grow at a strong compound annual growth rate (CAGR) of 7.8% between 2023 and 2027 to reach $13.9 trillion in 2027, forecasts GlobalData, a leading data and analytics company. An analysis of GlobalData’s Payment Cards Analytics reveals that the US card payments value, which registered a growth […]
Pfizer, Gilead, GSK to capture 62% of $150 billion infectious diseases market, says GlobalData
The infectious diseases market is forecast to grow at a compound annual growth rate (CAGR) of 5.7% between 2023 and 2029 to reach an impressive $150 billion in annual sales in 2029. The key players in this landscape include Pfizer Inc, Gilead Sciences Inc, and GSK plc, which are expected to collectively generate 62% of […]
Lilly donanemab flaunts strong clinical profile in data read-out, ready to compete with Leqembi if approved, says GlobalData
Following the news that Eli Lilly published full results from its TRAILBLAZER-ALZ 2 (NCT04437511) study of anti-amyloid-beta (Aβ) monoclonal antibody (mAb), donanemab, in Alzheimer’s disease (AD); Rose Joachim, Director of Neurology at GlobalData, a leading data and analytics company, offers her view: “On the heels of the US FDA’s approval of Eisai and Biogen’s Leqembi […]
Venture capital funding in China startups YoY drop 36.3% to $18.6 billion in H1 2023, reveals GlobalData
Venture capital (VC) funding activity in China witnessed a considerable year-on-year (YoY) decline in terms of deal volume as well as value during the first half (H1) of 2023. A total of 1,622 VC funding deals of worth $18.6 billion were announced in China during H1 2023. This represents a YoY decline of 15.8% in […]
GenAI revolutionizes customer communication channels in retail, says GlobalData
From revolutionizing the nuts and bolts of supply chain operations to turbo-charging customer service, generative artificial intelligence (genAI) stands on the forefront of innovation in retail. Its ability to fabricate hyper-customized content is turning the tables in marketing and communication strategies, says GlobalData, a leading data and analytics company. Kiran Raj, Practice Head of Disruptive […]
Chile real GDP to contract in 2023, forecasts GlobalData
The economy of Chile is expected to face several challenges in 2023, including lower copper production, fluctuations in commodity prices, high inflationary pressures, strict monetary policies, and low business confidence. These factors are likely to have a dampening effect on investments and domestic demand, resulting in subdued economic activities. Additionally, the global economic slowdown is […]
China in-house R&D paves way for improved access to KRAS G12C inhibitors for NSCLC, says GlobalData
China is emerging as a key player in developing novel oncology therapies, particularly in treating non-small cell lung cancer (NSCLC). Kirsten rat sarcoma homolog (KRAS) G12C inhibitors have gained significant attention for their efficacy in targeting KRAS G12C mutations, prevalent in NSCLC. China’s robust pipeline of in-house developed therapies targeting these mutations promises future affordability […]
China economy to face slowdown amidst deflationary pressures, foresees GlobalData
China’s economy displayed a strong rebound since December 2022, with an average annual growth rate of 5.5% in the first half (H1) of 2023. However, the current economic landscape presents challenges that defy expectations of a robust post-COVID-19 recovery. Stagnant consumer prices and a continuous decline in the producer price index indicate sluggish demand conditions, […]
Average premium earned by top 20 global public insurers up by 3.3% in 2022, reveals GlobalData
The top global public insurance companies sustained their momentum in 2022, benefiting from increased insurance awareness following the COVID-19 pandemic and an economic rebound in most global markets. The average premium earned* of the top 20 global insurers grew by 3.3% while experiencing a slight 2.3% decline in total revenue, reveals GlobalData, a leading data […]
15 of top 20 biopharmaceutical companies by revenue report 5.2% YoY growth in 2022, reveals GlobalData
The biopharmaceutical industry had an exceptional year in 2022 with notable success for those with COVID-19 vaccines. The majority (15) of the top 20 publicly traded global innovative biopharmaceutical companies reported a 5.2% growth in the aggregate revenue to $868.97 billion from 2021 to 2022, reveals GlobalData, a leading data and analytics company. GlobalData […]
Quest Diagnostics launch of DTC genetic test momentous event, says GlobalData
Quest Diagnostics has launched a direct-to-consumer (DTC) genetic test “Genetic Insights”, highlighting the continued growth potential of the market. This is in large part due to more consumers becoming eager to learn their genetic profiles and make decisions about their health, or to simply gain knowledge of their ancestral information, says GlobalData, a leading data […]
FIFA Women’s World Cup 2023 to net $307.92 million in annual value from main sponsorship inventory, says GlobalData
Women’s soccer and sport in general is on the rise, enjoying a wave of popularity that is resulting in even greater commercial/brand interest. For the first time in the organizations history, FIFA has separated the commercial inventory for its Women’s World Cup 2023. FIFA has been active in signing new partnerships to this year’s event […]
China success story in homegrown CAR-T therapies development continues with Fucaso approval, says GlobalData
The National Medical Products Administration (NMPA) has recently approved Innovent Biologics and IASO Bio’s CAR-T therapy equecabtagene autoleucel (Fucaso) for the treatment of relapsed and/or refractory multiple myeloma (R/R MM). It will be the first CAR-T therapy for MM patients and second one by a homegrown company in China. The approval will further boost CAR-T […]
UK startups raise $7.2 billion VC funding in H1 2023, reveals GlobalData
A total of 706 venture capital (VC) funding deals worth $7.2 billion were announced in the United Kingdom during the first half (H1) of 2023. Both VC funding deals volume and value witnessed a considerable year-on-year (YoY) decline during the period. While the number of VC funding deals declined by 28.6%, the corresponding deal value […]
Twitter influencers see Ripple win over SEC as big leap for crypto industry, says GlobalData
The XRP cryptocurrency price exploded, and its market capitalization spiked up above $46 billion following the news that Ripple Labs Inc has won a case against the US Securities and Exchange Commission (SEC) on 13 July 2023. In line with this, Twitter influencer conversations around XRP witnessed a whopping spurt, reveals the Social Media Analytics […]
Ripple Labs win over SEC sparks crypto market surge and paves way for industry shift, says GlobalData
Following the news that Ripple Labs has won a case against the US Securities and Exchange Commission (SEC); Nicklas Nilsson, Thematic Intelligence Consultant at GlobalData, offers his view: “The US judge ruled that the open market sales of XRP, Ripple’s cryptocurrency developed for cross-border payments, do not classify as a security. The ruling will have […]
Asia-Pacific deal activity down by 20.9% YoY in H1 2023, reveals GlobalData
A total of 7,245 deals (mergers & acquisitions (M&A), private equity, and venture financing deals) were announced in the Asia-Pacific (APAC) region during the first half (H1) of 2023, which was a decline of 20.9% over 9,154 deals announced during the same period in 2022, reveals GlobalData, a leading data and analytics company. An analysis […]
Venture capital funding in US plunges 49.2% YoY to $64.6 billion in H1 2023, reveals GlobalData
Venture capital (VC) funding activity in the US witnessed a massive decline during the first half (H1) of 2023. A total of 4,218 VC deals with disclosed funding value of $64.6 billion were announced in the US during H1 2023. This represents a year-on-year (YoY) decline of 34.7% in terms of volume and 49.2% drop […]